TylickiL., NieweglowskiT., BiedunkiewiczB.. The influence of ozonated autohemotherapy on oxidative stress in hemodialyzed patients with atherosclerotic ischemia of lower limbs.Int J Artif Organs2003; 26: 297–303.
3.
TylickiL., BiedunkiewiczB., NieweglowskiT.. Ozonated autohemotherapy in patients on maintenance hemodialysis: Influence on lipid profile and endothelium.Artif Organs2004; 28: 234–7.
4.
TylickiL., LizakowskiS., BiedunkiewiczB.. Platelet function unaffected by ozonated autohemotherapy in chronically hemodialyzed patients.Blood Coagul Fibrinolysis2004 (in press).
5.
BiedunkiewiczB., TylickiL., Lichodziejewska-NiemierkoM., LiberekT., RutkowskiB.. Ozonetherapy in a dialyzed patient with calcific uremic arteriolopathy.Kidney Int2003; 64: 367–8.
6.
TylickiL., NieweglowskiT., BiedunkiewiczB., BurakowskiS., RutkowskiB.. Beneficial clinical effects of ozonated autohemotherapy in chronically dialysed patients with atherosclerotic ischemia of the lower limbs-pilot study.Int J Artif Organs2001; 24: 79–82.
7.
BiedunkiewiczB., TylickiL., NieweglowskiT., BurakowskiS., RutkowskiB.. Clinical efficacy of ozonated autohemotherapy in hemodialyzed patients with intermittent claudication: An oxygen controlled study.Int J Artif Organs2004; 27: 29–34.